New Therapies of Neovascular AMD beyond Anti-VEGF Injections

Neovascular age-related macular degeneration is a leading cause of vision loss among the aging population. The current standard of care to treat neovascular age-related macular degeneration is inhibiting vascular endothelial growth factor (VEGF) through intravitreal injections. Recent studies have d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahn, Greggory M., Khanani, Arshad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835944/
https://www.ncbi.nlm.nih.gov/pubmed/31735879
http://dx.doi.org/10.3390/vision2010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835944/
https://www.ncbi.nlm.nih.gov/pubmed/31735879
http://dx.doi.org/10.3390/vision2010015

Ejemplares similares